Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals company information, Employees & Contact Information

Updated June 2026

Quick answer

Gilgamesh Pharmaceuticals is a Pharmaceutical Manufacturing company and founded in 2019. It has approximately 34 employees on record. Contact data was last refreshed in June 2026. Find Gilgamesh Pharmaceuticals's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access

Company Details

Employees
34
Founded
2019
Address
113 University Pl,
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Provider jobs.
HQ
New York, New York
Looking for a particular Gilgamesh Pharmaceuticals employee's phone or email?

Gilgamesh Pharmaceuticals Questions

News

Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder - PR Newswire

Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder PR Newswire

21.6-Point Depression Score Improvement: AbbVie Acquires Breakthrough Short-Acting Psychedelic Drug - Stock Titan

21.6-Point Depression Score Improvement: AbbVie Acquires Breakthrough Short-Acting Psychedelic Drug Stock Titan

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments - Psychedelic Alpha

Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments Psychedelic Alpha

Gilgamesh Pharma to Webcast Live at VirtualInvestorConferences.com April 28th - GlobeNewswire

Gilgamesh Pharma to Webcast Live at VirtualInvestorConferences.com April 28th GlobeNewswire

Gilgamesh Appoints New Members to Board of Directors - citybiz

Gilgamesh Appoints New Members to Board of Directors citybiz

Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depressive Disorder (MDD) - PR Newswire

Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depressive Disorder (MDD) PR Newswire

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round - Psychedelic Alpha

Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round Psychedelic Alpha

Top Gilgamesh Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant